Post-Marketing Safety Study in Japan in Participants With High Risk of Severe Exacerbation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine

NCT05894525 · clinicaltrials.gov ↗
COMPLETED
Status
8844
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

ModernaTX, Inc.